2025. Experience in switching monoclonal antibodies in a patient with severe refractory atopic dermatitis: from Dupilumab to Abrocitinib. Case report . Revista Alergia México. 72, 4 (Dec. 2025), 382–385. DOI:https://doi.org/10.29262/ram.v72i4.1547.